Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
An update from GoodRx Holdings ( (GDRX) ) is now available.
On January 21, 2025, GoodRx Holdings announced the appointment of Scott Wagner as a Class II director and Co-Chair of the Board, following his tenure as Interim CEO. Wagner’s extensive leadership experience, including his role at GoDaddy, is expected to enhance the company’s strategic direction. Simon Patterson resigned from the Board, with no disagreements cited, and his vacancy was filled by Wagner. Wagner will receive compensation in line with GoodRx’s Non-Employee Director Compensation Program.
More about GoodRx Holdings
GoodRx Holdings operates in the digital healthcare sector, focusing on providing consumers with access to affordable prescription medications through its platform.
YTD Price Performance: 3.29%
Average Trading Volume: 1,484,860
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $1.8B
See more insights into GDRX stock on TipRanks’ Stock Analysis page.
